9,10-anthraquinone has been researched along with ganciclovir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Al-Mahdi, Z; Alam, Z; Kellogg, GE; Kuchta, A; McKee, Z; McVoy, MA; Parikh, HI; Parris, DS; Zhu, Y | 1 |
2 other study(ies) available for 9,10-anthraquinone and ganciclovir
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL.
Topics: Anthraquinones; Antiviral Agents; Cell Line; Cell Survival; Cytomegalovirus; DNA, Viral; Emodin; Ganciclovir; Gene Expression; Humans; Immediate-Early Proteins; Sulfonic Acids; Virus Replication | 2015 |